Joseph Foley
New player in the Pharma adhesives market
English Version
Facundo Schiavone (ex Andreani) and Jorge Muixi (ex H.B. Fuller) have launched a new company in the Argentine market.
Facundo Schiavone (ex Andreani) and Jorge Muixi (ex H.B. Fuller) have launched a new company in the Argentine market.
With an initial investment of $10 million, the firm will focus on the specialist adhesives sector, catering for different industries,...
Marken (soon to be UPS) cuts the ribbon at new facilities...
English Version
Pharmabiz was present as the clinical trials logistics company Marken cut the ribbons on a new operations centre yesterday.
Pharmabiz was present as the clinical trials logistics company Marken cut the ribbons on a new operations centre yesterday.
The company’s global CEO Wes Wheeler attended the event, along with its...
Dufour returns in the hands of home cleaning products
English Version
Argentine men's deodorant and fragrance brand Dufour is returning in the hands of the owners of a classic home cleaning product.
Argentine men's deodorant and fragrance brand Dufour is returning in the hands of the owners of a classic home cleaning product.
The brand is being relaunched by local firm Villard & Louis, makers...
Argentine pharma companies looking abroad
English Version
Argentine firms feeling the pinch from an ongoing recession at home are looking abroad for expansion.
Argentine firms feeling the pinch from an ongoing recession at home are looking abroad for expansion.
Several local firms are looking to enter new markets and create alliances, mainly in the areas of generics...
Traceability: new rules
English Version
As predicted by Pharmabiz, Argentina's regulator ANMAT has introduced new rules for drugs traceability.
Ruling number 10564, published in Argentina's governmental bulletin, merges previous lists of active ingredients that must be traced, and adds more.
The measure updates lists published in 2011, eliminating close to 100 drugs listed in four rulings emitted...
Richmond continues regional expansion with new company in Uruguay
English Version
Argentine drugmaker Richmond, led by Marcelo Figueiras, has informed the country's national securities commission that is has decided to register a limited company in Uruguay.
Argentine drugmaker Richmond, led by Marcelo Figueiras, has informed the country's national securities commission that is has decided to register a limited company in Uruguay.
The new...
Droguería del Sud opens new facilities
English Version
Argentine president Mauricio Macri cut the ribbon at Droguería del Sud's new central distribution centre in the province of Buenos Aires.
Argentine president Mauricio Macri cut the ribbon at Droguería del Sud's new central distribution centre in the province of Buenos Aires.
Pharmabiz was present at the event, at which Drogería del Sud's president,...
Indian drugmakers focus on Latin America
English Version
India’s phamaceutical industry continues to look for strategic allies in Latin America and seems to have its eyes on Peru.
India’s phamaceutical industry continues to look for strategic allies in Latin America and seems to have its eyes on Peru.
In Argentina, inroads had been made during the previous government’s administration, led by Cristina Fernández...
Colorcon: new CEO and projects
Colorcon has a new regional CEO. Now at the helm in South America is Rafael Falco, who was previously the company’s sales manager for the southern cone.
English Version
The multinational Colorcon, specialised in colourings and coatings for medicines, has a new regional CEO.
Now at the helm in South America is Rafael Falco, who was previously the company’s sales...
Layoffs at AstraZeneca
Anglo-Swedish drugmaker AstraZeneca is laying off 100 employees in Argentina. Under new CEO Gustavo Mizraje, the local operation is making the cuts in the areas of administration and marketing
English Version
Anglo-Swedish drugmaker AstraZeneca is laying off 100 employees in Argentina, Pharmabiz has learned.
Under new CEO Gustavo Mizraje, the local operation is making the cuts in the...
More layoffs at Biogen
English Version
Global biotech firm Biogen continues to lay off staff in Argentina while rumours circulate that it might leave the country altogether.
Global biotech firm Biogen continues to lay off staff in Argentina while rumours circulate that it might leave the country altogether.
The latest news obtained by Pharmabiz is that the multinational...
Bayer event: focus on Latin America
English Version
Bayer brought together a legion of Latin American journalists for a press conference in Buenos Aires to outline its plans for the continent and detail its performance in each country.
Bayer brought together a legion of Latin American journalists for a press conference in Buenos Aires to outline its plans for...
Danish drugmaker lays off local director
Alberto Weder’s 15-year tenure at the helm of Danish drugmaker Lundbeck’s Argentine concern has been brought to an end.
English version
Alberto Weder’s 15-year tenure at the helm of Danish drugmaker Lundbeck’s Argentine concern has been brought to an end, Pharmabiz has learned.
For the moment, finance director Enrique Alba Valle is acting...
Argentine biotech firm in crisis: debts and layoffs
Sources say the company is considering opening crisis prevention talks with Argentina’s Ministry of Work, but official spokesmen have denied this.
English Version
Argentine biotech firm Amega Biotech is facing financial difficulties and has begun making layoffs, Pharmabiz has learned.
The company officially admitted to Pharmabiz that it has already cut 20 jobs from a total of 300 staff, but reliable...
AstraZeneca signs licensing deal
Swiss/British drugmaker AstraZeneca has closed a new licensing agreement with Argentine firm GP Pharm, Pharmabiz can exclusively reveal.
English Version
Swiss/British drugmaker AstraZeneca has closed a new licensing agreement with Argentine firm GP Pharm, Pharmabiz can exclusively reveal.
The licensing and royalties agreement will see GP Pharm commercialise the injectable drugs Yectafer, Nubaína, Intrafer, Fentanilo and Remicit, which AZ produces at its plant in...
German drugmaker Stada buys Argentine generics producer
The post-Davos influx of foreign investment appears to be arriving more quickly than expected, starting with German drugmaker Stada's purchase of Argentine generics producer Vannier.
English Version
The post-Davos influx of foreign investment appears to be arriving more quickly than expected, starting with German drugmaker Stada's purchase of Argentine generics producer Vannier. See website.
The transaction, completed...
Argentina signs Hepatitis C agreement
The Argentine health ministry today signed a u$s 5.4 million contract for the direct purchase of Hepatitis C treatments Sovaldi and Probirase.
English Version
The Argentine health ministry today signed a 72 million pesos ($5.4 million) contract for the direct purchase of Hepatitis C treatments Sovaldi and Probirase.
The agreement was signed today by health minister Jorge Lemus. See...
Argentine firm buys German plant
Argentine businessman Jorge Braver has bought an oncology plant from German firm Fresenius Kabi's – specialists in infusion therapy and parenteral nutrition.
English Version
Argentine businessman Jorge Braver has bought an oncology plant from German firm Fresenius Kabi's – specialists in infusion therapy and parenteral nutrition.
A strong man in the Cooperala industrial chamber who likes to hold his meetings...
Eurofarma buys Sanofi Argentine plant
English Version
Brazilian firm Eurofarma has bought Sanofi’s plant in Lomas del Mirador, Argentina. The decision comes after a long process of due diligence in which the company, overseen by Mauricio Billi, looked closely at its figures.
Brazilian firm Eurofarma has bought Sanofi’s plant in Argentina. The decision comes after a long process of due diligence in which the company, overseen...
Unilever sells Argentine brands and plant
The operation still needs the OK from the Argentine secretary of commerce but is expected to get the go-ahead.
English Version
Unilever sells Argentine brands and plant British-Dutch multinational Unilever has sold off a package of personal care brands, reliable market sources have told Pharmabiz. The move is intended to redress the monopolistic position...
Health minister in India
Argentine health minister Daniel Gollan is in India attempting to establish agreements with generics manufacturers, Pharmabiz has learned from reliable sources.
English Version
Argentine health minister Daniel Gollan is in India attempting to establish agreements with generics manufacturers, Pharmabiz has learned from reliable sources.
The objective of the trip is to add...
Murray: global pharma perspectives
New Zealander Murray Aitken, Executive Director of IMS Institute for Healthcare Informatics, arrived in Argentina to give his global perspectives.
English Version
New Zealander Murray Aitken –Executive Director of IMS Institute for Healthcare Informatics- arrived in Argentina to give his global perspectives.
Aitken explained which therapeutic areas were the most important and grew at the fastest...
Novartis sells local brand in Argentina
Swiss pharmaceutical company Novartis has sold its leading local anti-nausea brand Reliverán to Argentine firm Gador.
English version
Swiss pharmaceutical company Novartis has sold its leading local anti-nausea brand Reliverán to Argentine firm Gador.
The transaction was closed in Buenos Aires on Friday April 24 and was confirmed to Pharmabiz by Víctor...
Layoffs and restructuring at GSK
English Version
Pharma multinational GSK this week sat at the table at the Argentine Ministry of Work opposite the trade union for pharmaceutical sales representatives. The cause was the mandatory arbitration ordered by the Ministry after the company laid off 15 employees
Pharma multinational GSK this week sat at the table at...
HLB buys AstraZeneca Rontag line
English Version
Argentine firm HLB Pharma led by Hernán López Bernabó has acquired the Rontag line from British-Swedish multinational AstraZeneca for close to ten million pesos.
Argentine firm HLB Pharma led by Hernán López Bernabó has acquired the Rontag line from British-Swedish multinational AstraZeneca for close to ten million pesos (USD...
Nestlé signs deal with Cassará
Swiss multinational Nestlé has closed a deal with Argentine pharma company Cassará to expand its presence in the local market.
English Version
Swiss multinational Nestlé has closed a deal with Argentine pharma company Cassará to expand its presence in the local market.
The contract was signed last Tuesday at the headquarters of Nestlé Argentina. Present were Jason Stalker, Nestlé's regional CFO...
Phytomedicine approval in Uruguay
English Version
Uruguayan firm Botica del Señor has launched a medicine derived from chamerion angustifolium to be used for the treatment of benign prostatic hyperplasia.
Uruguayan firm Botica del Señor has launched a medicine derived from chamerion angustifolium, a plant commonly known as fireweed or rosebay willowherb, to be used for the treatment of benign prostatic hyperplasia.
Pharmabiz...
Sidus reduces staff by 30%
Argentine pharmaceutical group Sidus has completed a round of voluntary redundancies covering all areas of the company. The deadline for take-up was Friday October 31.
English Version
Argentine pharmaceutical group Sidus has completed a round of voluntary redundancies covering all areas of the company. The deadline for take-up was Friday October 31.
The company's objective was to reduce staff levels...
Savant opens new plant
The Argentine pharmaceutical company Savant has cut the ribbon at a new softgel capsule plant in the town of El Tío, Córdoba.
English version
In Córdoba– The Argentine pharmaceutical company Savant has cut the ribbon at a new softgel capsule plant in the town of El Tío, Córdoba.
During a tour of...
Abbott acquires Recalcine
US pharma company Abbott has completed its acquisition of Chilean firm CFR Recalcine, doubling its presence in the Latin American generics market.
English version
US pharma company Abbott has completed its acquisition of Chilean firm CFR Recalcine, doubling its presence in the Latin American generics market. See press release
Abbott secured more than 99% of CFR’s common stock via a takeover...
Roemmers signs license for Menarini line
Argentina's Roemmers group has signed an agreement to take on most of the products belonging to Italian pharmaceutical firm Menarini, which abandoned Argentina in April.
English version
Argentina's Roemmers group has signed an agreement to take on most of the products belonging to Italian pharmaceutical firm Menarini, which abandoned Argentina...
Ferring sold Dupomar to Investi
The Swedish laboratory Ferring has sold the Dupomar line, which they had acquired ten years before, to the national company Investi.
English version
The Swedish laboratory Ferring has sold the Dupomar line, which they had acquired ten years before, to the national company Investi.
The $ 4 million deal comprises the sale of Calcio Base Dupomar, Citramar, Deltrox, Filotricin, Mar-V and Piroxicam.
The transaction...
Argentine government adds three vaccines
Argentine president Cristina Fernández de Kirchner has announced the addition of three new vaccines to the country's official immunisation schedule at a cost of $82 million.
English version
Argentine president Cristina Fernández de Kirchner has announced the addition of three new vaccines to the country's official immunisation schedule at a cost of $82...
Bagó forms new company
Argentine company Bagó has entered a joint venture with Dutch firm Synthon. The new enterprise, Synthon Bagó, is to specialise in multiple sclerosis.
English version
Argentine company Bagó has entered a joint venture with Dutch firm Synthon.
The new enterprise, Synthon Bagó, is to specialise in multiple sclerosis.
The agreement, sealed in Amsterdam,...
GSK & Elea sell non-core products
The Argentinean laboratory Elea and the British company Phoenix –which is part of the firm GlaxoSmithKline – have sold many of their non-core products in Argentina.
English version
The Argentinean laboratory Elea and the British company Phoenix –which is part of the firm GlaxoSmithKline – have sold many of their non-core...
Menarini to cease operations in Argentina
The Italian laboratory Menarini has decided to close its operations in Argentina. The decision was announced yesterday at the Ministry of Labor after a meeting on previously announced layoffs.
English version
The Italian laboratory Menarini has decided to close its operations in Argentina.
The company formally announced the decision yesterday at the Ministry of Labor after a meeting on previously...
GSK came out swinging
The British Company GSK has touched several sore spots in its latest annual report with strong statements about intellectual property, pricing controls, and emerging markets’ protectionist policies.
English version
The British Company GSK has touched several sore spots in its latest annual report with strong statements about intellectual property, pricing controls,...
Valeant – on a nosedive due to devaluation?
Pharmaceutical company B+L, now renamed Valeant, is downsizing on a major scale in Argentina.The first step came back in September when the company cut ties with Máximo Pförtner.
English version
Pharmaceutical company B+L, now renamed Valeant, is downsizing on a major scale in Argentina.
The first step came back in September when the company cut...
Congress: prices, industry and more
Argentine president Cristina Fernández de Kirchner opened the 132nd assembly of the National Congress in Buenos Aires on Saturday, marking the start of the 2014 legislative sessions.
English version
Argentine president Cristina Fernández de Kirchner opened the 132nd assembly of the National Congress in Buenos Aires on Saturday (March 1), marking the start of the 2014 legislative...
Savant: Corporate Bonds with Bancor, James, and Others
The national laboratory Savant revamped its name. The company that was founded by Mauro Bono now changed its name to “Savant” in a strategic reduction associated with simplicity.
English Version
The national laboratory Savant revamped its name. The company that was founded by Mauro Bono now changed its name to “Savant” in a strategic reduction associated with simplicity.
However, Savant...
Dromex: new softgel plant
Julio Scardigli's Dromex Group has cut the ribbon on a new soft capsule plant at the recently-opened Ezeiza industrial estate in the province of Buenos Aires.
English version
Julio Scardigli's Dromex Group has cut the ribbon on a new soft capsule plant at the recently-opened Ezeiza industrial estate in the province...
Hané and Hernán Bernabó, allies
The noted Jorge Hané and the no less renowned pharmaceutical businessman Hernán López Bernabó signed an agreement between companies.
English version
The noted Jorge Hané and the no less renowned pharmaceutical businessman Hernán López Bernabó signed an agreement between companies.
They both put their signatures so that the popular product Reduce Fat...
Capano, end to a stage in B.I
After 21 years in the company, Fabio Capano leaves the German Boehringer Ingelheim as of January 2014.
English version
Fabio Capano leaves the German Boehringer Ingelheim as of January 2014.
It will be after 21 years in the company and the last six months as the main responsible person for the South...
Pfizer – Another Woman at the Forefront
The American Pfizer has appointed Adriana Belardinelli as site manager of its manufacturing plant in Argentina.
English version
The American Pfizer has appointed Adriana Belardinelli as site manager of its manufacturing plant in Argentina.
With this decision, the company has put two women in key positions to carry out the most...
Roemmers Launches Nutraceutical
Roemmers group launched a line of instant formulas named Nutri Baby through its laboratory Argentia.
English version
Roemmers group launched a line of instant formulas named Nutri Baby through its laboratory Argentia.
This new business unit is based on the acquisition of the small local firm Nutry Baby which the company made about three years...
MSD: Dismissals Are Coming
The American company Merck announced a global initiative aiming to focus on R&D as well as cutting back on trade costs.
English version
The American company Merck announced a global initiative aiming to focus on R&D as well as cutting back on trade costs.
In the context of that plan, it will dismiss 20% of its...
Milk: No More Nestlé?
Baby formula market is changing by leaps and bounds in the region. It is a constantly growing business on which mega companies have had their eyes over the last few years.
English version
Baby formula market is changing by leaps and bounds in the region. It is a constantly growing business...
GSK in the limelight over bribery allegations
Pharmaceutical company GSK is on tenterhooks after the Chinese government accused it of being behind a massive corruption scandal.
English version
Pharmaceutical company GSK is on tenterhooks after the Chinese government accused it of being behind a massive corruption scandal.
It is suspected of paying bribes to doctors, hospitals and bureaucrats, among...
Cassará in 50-50 partnership with APOTEX
The national firm Laboratorios Cassará reached an agreement with the Canadian company Apotex in order to participate in its local operation.
English version
The national firm Laboratorios Cassará reached an agreement with the Canadian company Apotex in order to participate in its local operation.
Therefore, the company which landed in Argentina in 2011 implementing...
Roemmers Opens Dermo-cosmetic Division
Roemmers Group continues to create new business units and to forge projects. This time, it gave shape to its division baptized Belleza y Salud -Beauty and Health.
English version
Roemmers Group continues to create new business units and to forge projects.
This time, it gave shape to its division baptized Belleza y Salud...
LiquidCap: new capsules with liquid
The national laboratory Novocap is tying its boots to go out into the field with a cutting-edge and differentiated technology in the local market.
English Version
The national laboratory Novocap is tying its boots to go out into the field with a cutting-edge and differentiated technology in the local market....
IMS World Review: emerging countries, prices and more
The IMS World Review 2013 took place today at the Buenos Aires Auditorium in the Recoleta neighbourhood. The event had a special flavour this year because IMS is celebrating 40 years in Argentina.
English version
The IMS World Review 2013 took place today at the Buenos Aires Auditorium in the Recoleta neighbourhood. The event...
Maprimed, renegotiation and capital contribution
The leading producer of active pharmaceutical ingredients (APIs) in Argentina had adverse results in the 2012 business year that continued during the first quarter of 2013.
English version
The leading producer of active pharmaceutical ingredients (APIs) in Argentina had adverse results in the 2012 business year that continued during the first...
Valeant acquires Bausch + Lomb
The Canadian pharmaceutical company Valeant, agreed to acquire the laboratory specialized in ophthalmology Bausch & Lomb, owned by the Warburg Pincus fund.
English version
The Canadian pharmaceutical company Valeant, which sold its assets in Argentina in 2008, agreed to acquire the laboratory specialized in ophthalmology Bausch & Lomb, owned by the Warburg Pincus fund.
In order to carry...
Genomma bought Piecidex
English Version
The mexican laboratorio Genomma is looking for new brands to reinforce its growth in the dermocosmetics and over the counter medicine business. Therefore, it recently acquired Piecidex from the national company Andrómaco.
Mexican laboratory Genomma acquired Piecidex from the Argentine firm Andrómaco.
In this way, the company that is steadily climbing...